Alder BioPharmaceuticals Inc - Company & Market Research Reports

Alder BioPharmaceuticals is a clinical-stage biopharmaceutical company that develops and commercializes therapeutic antibodies. Its lead product candidate is Eptinezumab, a monoclonal antibody that inhibits calcitonin gene-related peptide (CGRP). Its being developed as a migraine prevention treatment for patients with chronic and frequent episodic migraine. The company is also evaluating ALD1910, which is designed to specifically inhibit pituitary adenylate cyclase-activating peptide-38. Alder was founded in 2002 and is headquartered in Bothell, Washington.

From
From
From
From
From
From
From
Global Analgesics Market 2016-2020 - Product Thumbnail Image

Global Analgesics Market 2016-2020

  • Report
  • 102 Pages
From
From
From
From
From
From
Loading Indicator
adroll